Home > News > SABioscience products now available through QIAGEN subsidiaries
Industry Updates New Products Supplier News Upcoming Events business web

SABioscience products now available through QIAGEN subsidiaries

Hits:3342   Date: 7/6/2010
Powerful technologies for pathway expression analysis

With the acquisition of SABiosciences, we now offer the most comprehensive portfolio of sample and assay technologies for pathway analysis currently available.
RT² Profiler PCR Arrays enable simultaneous expression analysis of panels of genes associated with any one of over 100 biological pathways or disease states . These ready-to-use arrays are experimentally tested and verified for every human, mouse, and rat gene. In combination with data analysis tools and sample technologies, you have all you need for pathway analysis from sample to result.

Pathway-focused gene expression analysis is quick and easy at the PCR array data analysis Web portal.

PCR array data analysis

What is a PCR array? An advanced new technology that can be used in any laboratory with access to a real-time PCR instrument.

Watch the video

About QIAGEN

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN’s assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. QIAGEN employs more than 3,500 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/ .